Leadership Team Expansion Announced by Command Medical: Includes William King & Chad Tremaroli

Command Medical Products has announced that William King and Chad Tremaroli are new additions to the Command Medical’s leadership team. King and Tremaroli Both filling new positions created to support the company’s focus on improved customer experience and sustaining the ongoing expansion of the organization.

William King joins Command Medical as the quality assurance and regulatory compliance manager. His prior role as quality systems and regulatory manager at Steris Isomedix bring excellent depth and experience in sterilization and regulatory compliance to the Command team. Bill’s previous positions at PerkinElmer and OMNIlife sciences support Command Medical’s strategic goals for optimization and improved customer experience in the quality and regulatory operations of the business. Bill has assumed the role of Command Medical’s management representative with the FDA and ISO notified body, SGS from Robert Wise. This transition of responsibilities will enable Robert to provide focused customer support in a variety of quality related contexts.

Chad Tremaroli has assumed the Director of Operations role at Command Medical’s Florida manufacturing facility. Previously, John Basham, who was also Director of Engineering, held this position. The splitting of this role into two separate functions aligns with Command Medical’s future strategic organizational structure. John will retain the Director of Engineering role as Chad focuses on operational improvements supported by his prior fourteen years’ experience working for Medtronic in senior leadership positions in logistics, distribution, continuous improvement and value stream management.

“It is an exciting time for Command Medical,” shared Jim Carnall, Command Medical’s president and COO. “Our vision to create a customer centric business is coming to fruition. Through transparent and responsive customer service, we are differentiating Command as a company that is truly focused on customer service beyond the traditional benchmarks of on time delivery and high quality. We offer direct communication to all department leaders and encourage open collaboration and sharing of knowledge with our clients. In order to support this while growing our business, we needed to add resources. The addition of Bill and Chad are key steps in our overall plan to meet our goal in providing legendary customer service.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”